ClementSBraithwaiteSSMageeMF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553-591.
2.
SuhSParkM.Glucocorticoid-induced diabetes mellitus: an important but overlooked problem. Endocrinol Metab. 2017;32(2):180-189.
3.
WilliSKennedyABrantBP, et al. Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes. Diabetes Res Clin Pract. 2002;58(2):87-96.
4.
SeeligEMeyerSTimperK, et al. Metformin prevents metabolic side effects during systemic glucocorticoid treatment. Eur J Endocrinol. 2017;176:349-358.
5.
OhashiNTsujiNNaitoY, et al. Alogliptin improves steroid-induced hyperglycemia in treatment-naïve Japanese patients with chronic kidney disease by decrease of plasma glucagon levels. Med Sci Monit. 2014;20:587-593.
6.
KatsuyamaHSakoAAdachiHHamasakiHYanaiH.Effects of 6-month sitagliptin treatment on metabolic parameters in diabetic patients taking oral glucocorticoids: a retrospective cohort study. J Clin Med Res. 2015;7(6):479-484.
7.
WallaceMMetzgerN.Optimizing the treatment of steroid-induced hyperglycemia. Ann Pharmacother. 2017;52(1):86-90.
8.
UmpierrezGHellmanRKorytkowskiMT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2012;97(1):16-38.
9.
Tamez-PerezHQuintanilla-FloresDLRodriguez-GutierrezR, et al. Steroid hyperglycemia: prevalence, early detection and therapeutic recommendations: a narrative review. World J Diabetes. 2015;6(8):1073-1081.
10.
LakhaniOKumarSTripathiSDesaiMSethC.Comparison of two protocols in the management of glucocorticoid-induced hyperglycemia among hospitalized patients. Indian J Endocrinol Metab. 2017;21(6):836-844.
11.
American Diabetes Association. 15. Diabetes care in the hospital: Standards of Medical Care in Diabetes – 2021. Diabetes Care. 2021;44(suppl 1):S211-S220.
